Ablative Therapies for Liver Metastases of Gastroenteropancreatic Endocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|80|1|74-78

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.80, Iss.1, 2004-10, pp. : 74-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary

By  

Neuroendocrinology, Vol. 87, Iss. 1, 2007-11 ,pp. : 47-62

Karger

Access to resources Recommend Favorite

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

By  

Neuroendocrinology, Vol. 96, Iss. 4, 2012-04 ,pp. : 294-300

Karger

Access to resources Recommend Favorite

Chemotherapy for Gastro-Enteropancreatic Endocrine Tumours

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 79-84

Karger

Access to resources Recommend Favorite

Epigenetic Aspects on Therapy Development for Gastroenteropancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-03 ,pp. : 19-25

Karger

Access to resources Recommend Favorite

Therapeutic Monitoring of Gastroenteropancreatic Neuroendocrine Tumors: The Challenges Ahead

By  

Neuroendocrinology, Vol. 96, Iss. 4, 2012-10 ,pp. : 261-271

Karger

Access to resources Recommend Favorite